Similarly, in basal-like breast cancer, it enhances invasion through POU4F1 activation, promoting cell cycle progression and invasion, whereas TET1 inhibition reduces metastatic potential (Zhang et al., 2024a). This evidence concerns the gene POU4F1 and breast carcinoma.